Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-25 @ 4:11 PM
NCT ID:
NCT02761057
Group ID:
EG001
Title:
Cabozantinib
Description:
Experimental: Arm II (cabozantinib s-malate) Patients receive cabozantinib s-malate PO on days 1-42. Cycles repeat every 42 days in the absence of disease progression or unacceptable toxicity.
Drug: Cabozantinib S-malate Given PO
Other Names:
BMS-907351 Cabometyx CABOZANTINIB S-MALATE Cometriq XL-184 XL184
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
43
Other Number Affected:
41
Other Number At Risk:
43
Study:
NCT02761057
Results Section:
NCT02761057
Adverse Events Module:
NCT02761057